Press Release / Jun 21, 2012
Hovione’s sales grow 24%
Sales reach USD 180 million for the fiscal year ended March 31st 2012
Sales reach USD 180 million for the fiscal year ended March 31st 2012
PhD, MRPharmS as Vice President, Particle Design Business Unit
European Fine Chemicals Group Ratifies FDA's Proposed Generic Drug User Fees Act (GDUFA)
Top health and safety standards recognized